New federal price controls could hurt launch of new drugsBy The IJ Staff | February 04 2020 11:08AM
Ottawa’s new price controls for patented medicines in Canada are causing delayed product launches and a loss of jobs in the pharmaceutical industry, according to a survey of senior executives conducted for Life Sciences Ontario.
This article is reserved to PRO Level subscribers
Read the whole article….
$9.95 / month
The most popular in Health
Related to the same topic …